Critical Alert
HANDELNINE GLOBAL LLC Recalls Rheumacare capsules
This is a Class I recall — the most serious type. There is a reasonable probability of serious health consequences or death.
Source: FDA
CriticalRecall #D-0332-2026Drug / Pharmaceutical
HANDELNINE GLOBAL LLC Recalls Rheumacare capsules
HANDELNINE GLOBAL LLC · Class I — Most Serious
Product Description
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Reason for Recall
CGMP Deviations: product found to contain lead.
FDA Classification
Class I — Most Serious
A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Distribution
Product was distributed to one customer in NY.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class I recall — the FDA's most urgent classification — has been issued for a pharmaceutical product recalled by HANDELNINE GLOBAL LLC on December 22, 2025. CGMP Deviations: product found to contain lead. This recall affects 4 bottles /30 capsules each and was distributed nationwide. Class I recalls indicate a reasonable probability of serious health consequences or death. Consumers should stop using this product immediately.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.